UBS Group Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works (NYSE:BBWI) had its price objective raised by stock analysts at UBS Group from $17.00 to $22.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group‘s price objective suggests a potential upside of 2.64% from the company’s previous close.

A number of other research firms have also recently weighed in on BBWI. JPMorgan Chase & Co. lifted their price objective on Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research report on Tuesday, August 18th. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price for the company in a report on Tuesday, August 18th. Jefferies Financial Group increased their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Wells Fargo & Company raised their target price on shares of Bath & Body Works from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Thursday, October 29th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Tuesday, October 6th. Four investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Bath & Body Works has a consensus rating of “Hold” and an average price target of $22.53.

Bath & Body Works Price Performance

Shares of NYSE:BBWI traded up $0.35 during midday trading on Friday, hitting $21.43. The company had a trading volume of 1,505,969 shares, compared to its average volume of 5,949,377. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94. The company has a fifty day moving average of $19.16 and a two-hundred day moving average of $19.82. The company has a market cap of $4.32 billion, a price-to-earnings ratio of 5.58, a PEG ratio of 1.09 and a beta of 1.31.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the business earned $0.30 earnings per share. Bath & Body Works’s quarterly revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Research analysts expect that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. BlackRock Inc. purchased a new stake in Bath & Body Works in the second quarter worth about $449,065,000. Bank of America Corp DE purchased a new position in Bath & Body Works during the 2nd quarter valued at about $62,249,000. Bank of New York Mellon Corp purchased a new position in Bath & Body Works during the 2nd quarter valued at about $59,260,000. Arrowstreet Capital Limited Partnership increased its position in Bath & Body Works by 34.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock valued at $51,857,000 after purchasing an additional 707,449 shares during the period. Finally, Renaissance Technologies LLC raised its holdings in shares of Bath & Body Works by 885.7% in the 1st quarter. Renaissance Technologies LLC now owns 2,732,733 shares of the company’s stock valued at $51,020,000 after purchasing an additional 2,455,500 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.